1. Institute of Physiology, Charité — Universitätsmedizin Berlin, Berlin, Germany;
2. German Heart Institute Berlin, Berlin, Germany;
3. The Keenan Research Centre for Biomedical Science of St. Michael's, Toronto, Ontario, Canada;
4. Departments of Surgery and Physiology, University of Toronto, Toronto, Ontario, Canada;
5. Interdepartmental Division of Critical Care, Departments of Medicine and Biochemistry, University of Toronto, Toronto, Ontario, Canada;
6. Division of Pulmonary Pharmacology, Research Center Borstel, Borstel, Germany;
7. Institute of Immunology, University of Kiel, Kiel, Germany;
8. Institute of Immunology and Experimental Therapy, Wroclaw, Poland;
9. Institute of Functional and Applied Anatomy, Hannover Medical School, Hannover, Germany;
10. Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Member of the German Center for Lung Research (DLZ), Hannover, Germany;
11. Cluster of Excellence REBIRTH (From Regenerative Biology to Reconstructive Therapy), Hannover, Germany; and
12. Institute of Pharmacology and Toxicology, RWTH Aachen, Aachen, Germany